6 results

• Keytruda, Similar Cancer Drugs May Increase Risk of Pulmonary Embolism: Study

  October 17, 2024

  Martha Garcia

  New research indicates the use of certain cancer treatment drugs, like Keytruda and Opdivo, could pose a high risk of life-threatening cardiovascular events, adding to recent concerns about the class of medications.

• Tecentriq and Avastin Liver Cancer Combo Linked to Patient Deaths in Early Trials

  April 18, 2023

  Martha Garcia

  Some patient deaths have been linked to a clinical trial using a combination of Tecentriq and Avastin to prevent the return of liver cancer.

• Keytruda, Tecentriq Get New Bladder Cancer Restrictions From FDA

  June 25, 2018

  Irvin Jackson

  The FDA announced new bladder cancer restrictions on the use of Keytruda and Tecentriq, following indications that they could lower survival rates for some patients.

• Keytruda, Tecentriq Side Effects May Decrease Survival Chances In Some Patients: FDA

  May 21, 2018

  Irvin Jackson

  An FDA warning indicates that Keytruda and Tecentriq may decrease the risk of survival in certain metastatic urothelial cancer patients.

• Clinical Trial for Tecentriq-Cotellic Combo Halted After Patient Deaths

  April 13, 2018

  Irvin Jackson

  Roche has temporarily halted a clinical trial of a combination of the cancer drugs Tecentriq and Cotellic following the deaths of several patients involved in the study.

• Taxotere Found To Have More Side Effects, Lower Survival Rate Than Tecentriq: Study

  January 25, 2017

  Irvin Jackson

  A new study raises questions about the safety and effectiveness of Taxotere, which underperformed in both survival rates and side effects when compared to Tecentriq for treatment of lung cancer.